Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.
about
Hepatitis associated aplastic anemia: a reviewFirst-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemiaDonor Specific Anti-HLA Antibody and Risk of Graft Failure in Haploidentical Stem Cell TransplantationEltrombopag for the treatment of aplastic anemia: current perspectivesThe Latin American experience of allografting patients with severe aplastic anaemia: real-world data on the impact of stem cell source and ATG administration in HLA-identical sibling transplants.First-line matched related donor hematopoietic stem cell transplantation compared to immunosuppressive therapy in acquired severe aplastic anemia.The modern management of severe aplastic anaemia.Outcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic anemia in patients over 40 years of age.Post-transplantation cyclophosphamide for GVHD prophylaxis in severe aplastic anemiaRapid donor T-cell engraftment increases the risk of chronic graft-versus-host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromes.Single institution outcomes of treatment of severe aplastic anaemia.Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donorsImmunosuppressive treatment of acquired aplastic anemia and immune-mediated bone marrow failure syndromes.First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapyTreatment responses of childhood aplastic anaemia with chromosomal aberrations at diagnosis.Acquired aplastic anemia in children: incidence, prognosis and treatment options.A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapySuccess of allogeneic marrow transplantation for children with severe aplastic anaemia.Risk factors affecting outcome of second HLA-matched sibling donor transplantations for graft failure in severe acquired aplastic anemia.Parvovirus b19 associated hepatitis.Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen.Allogeneic haemopoietic stem cell transplantation in children: what alternative donor should we choose when no matched sibling is available?Management of adult patients older than 40 years refractory to at least one immunosuppressive course: HLA-identical sibling HSCT using fludarabine-based conditioning.Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations.Severe Aplastic Anemia following Acute Hepatitis from Toxic Liver Injury: Literature Review and Case Report of a Successful Outcome.Treatment of aplastic anaemia with lower-dose anti-thymocyte globulin produces similar response rates and survival as per standard dose anti-thymocyte globulin schedules.Hematopoietic stem cell transplantation for acquired aplastic anemia.A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations.Transplantation of highly purified CD34+ progenitor cells from alternative donors in children with refractory severe aplastic anaemia.Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia.Alternative donor HSCT in refractory acquired aplastic anemia - prevention of graft rejection and graft versus host disease by immunoablative conditioning and graft manipulation.Severe Aplastic Anemia following Parvovirus B19-Associated Acute Hepatitis.Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide.Related donor hematopoietic stem cell transplantation for Fanconi anemia without radiation: a single center experience in Turkey.Telomere length changes in patients with aplastic anaemia.CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic Transplantation.Improved survival in severe acquired aplastic anemia of childhood.Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: multicenter trial.Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia.
P2860
Q21245099-D2B7132F-B49D-405E-8D27-D0DDD278A1CEQ24201108-1750420D-7241-41FF-9801-FC997536D384Q26767440-66D80F12-48C0-4159-8AA3-C8FF1A1C2154Q28071710-05D83AE1-BC3D-4BA8-9367-3517A2EA0F7FQ31122890-290F2543-75EE-4003-82A1-9E14F778EAD1Q33889151-46DAA65E-A7D6-4414-97D6-CD13EB8FEEFFQ33994359-39025305-DDC0-440F-90F1-1D9F240EC500Q34108254-23D38D25-7D02-4C30-BDFA-5CE33F31F089Q34164154-3E2E77AF-5A70-4B4E-8C17-4D1159EFA4EEQ34228345-F63C0AF7-03AD-4DB5-B5D5-0C1DDE28C072Q34350974-6B11B35A-C16E-449D-8BF0-B65DF5281FFCQ34371142-7A930B1C-D68C-4343-9DD6-825F3527AD43Q34591766-6EAC600F-94BF-47DC-B887-9CBABFF65780Q34649082-AD4FB16D-5C10-4AAE-AF0A-776311D7FA56Q34722723-D068BA3B-5468-42F2-8A72-93D21F4701E5Q34975786-3F7CF1E1-4E41-4C63-B973-E7AF9EB24C1BQ35670980-0DC3A491-5C11-46CE-8472-125147686830Q35849011-3CF71CE8-33E6-44DF-8A45-72B2CC6F0395Q36958013-09623EB0-71EC-4BB7-82B5-95D98A44AC5CQ37216096-0388BAB2-4A7C-4A70-B016-98B1869978ABQ37285923-ECF8B1FA-6551-4B8B-B15B-6D96BB8EF261Q37334992-2E0E91F2-433D-4440-AD57-05DA0706F503Q37587374-98CB9C88-BAEF-4EB4-977D-FA1C70E3CDAFQ38065878-A30CA70D-29C5-4383-A388-1422AEB2DD9FQ38261555-25E3B399-BFBE-4BDD-92C7-8BB734EB9EC1Q38317932-99BCF375-84DC-411B-A5C2-D61FEDD43C66Q38893858-C0B276AF-4F29-4676-834E-132D4EB44859Q38949394-36D86E8C-75C6-4867-B819-2F34C99A9866Q39157279-200C113B-87BF-4FD9-8368-321348A2F748Q39678480-741A23D0-24E9-44FD-8DB8-84B634BB10EDQ39705843-5CFFF117-A320-4C8A-8C34-37F240F7232FQ40028514-E2EA839F-F310-4E5C-B320-DC349D44F3A6Q40198669-B4E5EED7-1B42-4BA0-862D-2F8DE05CAAEEQ43456564-96110B52-6CFB-4FC5-B4E4-62D33A098CCCQ43531912-E66B2CE7-729A-46D8-93AF-8DB44B10395EQ43572280-7F93A356-C996-4232-A3BF-E1E933BF1593Q43891811-08D69DAB-8BFC-4574-A2A0-17197F899421Q44800086-56D271C9-92AB-4A0C-89DD-D0E24A62F4C0Q45195281-1D97B107-01EC-426D-9CF7-3355E381399DQ45286067-E045C587-6FE4-4C95-B14E-2FB33C2A6758
P2860
Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Primary treatment of acquired ...... e Bone Marrow Transplant Team.
@en
Primary treatment of acquired ...... e Bone Marrow Transplant Team.
@nl
type
label
Primary treatment of acquired ...... e Bone Marrow Transplant Team.
@en
Primary treatment of acquired ...... e Bone Marrow Transplant Team.
@nl
prefLabel
Primary treatment of acquired ...... e Bone Marrow Transplant Team.
@en
Primary treatment of acquired ...... e Bone Marrow Transplant Team.
@nl
P1476
Primary treatment of acquired ...... e Bone Marrow Transplant Team.
@en
P2093
P304
P356
10.7326/0003-4819-126-2-199701150-00003
P407
P577
1997-01-01T00:00:00Z